Forte Biosciences (FBRX) Treasury Shares (2016 - 2020)

Forte Biosciences (FBRX) has reported Treasury Shares for 11 consecutive years, with $391437.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares rose 1159.17% year-over-year to $391437.0; the TTM figure through Mar 2026 stood at $391437.0 (up 1159.17% YoY), while the FY2025 annual figure was $47237.0, up 65.53% from the prior year.
• Treasury Shares grew to $391437.0 in Q1 2026 per FBRX's latest filing, from $47237.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $1.3 million in Q1 2023 and bottomed at $24387.0 in Q3 2025.
• Historically, Treasury Shares has averaged $400179.7 across 5 years, with a median of $162201.0 in 2022.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 1625.67% — and 2024, when it plunged 97.24%.
• Forte Biosciences' Treasury Shares stood at $162201.0 in 2022, then plunged by 73.96% to $42237.0 in 2023, then sank by 32.44% to $28537.0 in 2024, then jumped by 65.53% to $47237.0 in 2025, then soared by 728.67% to $391437.0 in 2026.
• Business Quant data shows FBRX's Treasury Shares at $391437.0 in Q1 2026, $47237.0 in Q4 2025, and $24387.0 in Q3 2025.